Watson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency Contraceptive
July 13 2012 - 9:21AM
Dow Jones News
By Melodie Warner
Watson Pharmaceuticals Inc.'s (WPI) generic version of Teva
Pharmaceutical Industries Ltd.'s (TEVA, TEVA.TV) Plan B One-Step
emergency contraceptive obtained U.S. Food and Drug Administration
approval.
Plan B One-Step, sometimes called the "day-after pill," is used
to prevent pregnancy following unprotected intercourse or a known
or suspected contraceptive failure.
Watson said it plans to immediately launch its product as Next
Choice One Dose.
The company said market-researcher IMS Health puts U.S. sales of
Plan B One-Step at $88 million for the year ending May 31.
In April, Watson reported its first-quarter earnings rose 22% as
it recorded sharply higher revenue with a boost from new generic
drugs and as its branded pharmaceuticals and distribution business
also posted double-digit growth.
-Write to Melodie Warner at melodie.warner@dowjones.com
Watson (NYSE:WPI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Watson (NYSE:WPI)
Historical Stock Chart
From Sep 2023 to Sep 2024